Kolexia
Le Saux Olivia Oncologie médicale
Le Saux Olivia
Oncologie médicale
Centre Léon-Bérard
Lyon, France
95 Activités
464 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Tumeurs du sein Pseudoxanthome élastique Carcinomes Métastase tumorale Carcinome épithélial de l'ovaire Tumeurs du rein Néphrocarcinome Tumeurs de la bouche

Collaborateurs

Voir plus
Freyer Gilles
Freyer Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Leger Falandry Claire
Leger Falandry Claire
Hôpital Lyon Sud, Pierre-Bénite, France
You Benoit
You Benoit
Hôpital Lyon Sud, Pierre-Bénite, France
Tredan Olivier
Tredan Olivier
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Clovis Oncology
4 collaboration(s)
Dernière en 2022
MSD
3 collaboration(s)
Dernière en 2023
OVERCOME
3 collaboration(s)
Dernière en 2020
Amgen
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
20P Deciphering tumor microenvironment heterogeneity between primary tumor and metastases in high grade serous ovarian cancer (HGSC) to predict response to immunotherapy (IT): Analyses from the NeoPembrOv/GINECO phase II trial
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
180P Immunogenomic profiling of the randomized NeoPembrOv clinical trial reveals the VEGFR2 angiogenic axis as a promising actionable target to overcome immunoresistance of high-grade ovarian carcinomas
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
752P Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic squamous cell cervix carcinoma: Subgroup analysis of the PEVOsq basket trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
PROADAPT: Prehabilitation & Rehabilitation in Oncogeriatrics: Adaptation to Deconditioning Risk and Accompaniment of Patients' With Cancer, a Multicenter Pilot Study
Essai Clinique (Hospices Civils de Lyon)   24 août 2023
Personality traits influence the psychophysiological anticipatory stress responses and the effectiveness of coping interventions
Proceedings of the 21st World Congress of Psychophysiology (IOP 2023) of the International Organization of Psychophysiology (IOP)   01 juin 2023
ADOPT-PRESTAGE: Randomized Controlled Trial on Acceptability, Diffusion and Impact on Treatment Adherence and Persistence of the PRESTAGE Program (Program for Education and Support for Oral Cancer Treatments in the Elderly) - Randomized Controlled Study Evaluating the Impact of the Program PRESTAGE
Essai Clinique (Hospices Civils de Lyon)   12 mai 2023
Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.
Cancers   30 septembre 2022
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
Cancers   25 février 2022
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.
Cancers   12 janvier 2022